SPO Global Inc. (SPOM)
Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents, vaccines for the Hepatitis B virus (HBV), monoclonal antibodies designed to detect male infertility, functional foods targeting cognitive disorders, and polypeptide-based probiotics.
Sector: Software - Application
Industry: Software - Application
SPO Global Inc.
OTC:SPOMTechnology · Software - Application
$0.0003
CLOSED · Nov 16Prev close$0.0003Close$0.0003
Mkt Cap$475K
EV-
Float213.35M
O/S1.58B
VOL12K sh
$ Vol$4
RVOL0.03×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
MCap$475KFloat213.35MO/S1.58B
Dilution
| Form | Description | Links | |
|---|---|---|---|